Patent · US Active

MLK4 gene, a new diagnostic and prognostic marker in cancers

US9127319B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Inventors

Alberto Bardelli · Baltimore, US
Miriam Martini · Torino, IT

Key dates

Filing date	Jun 15, 2010
Grant date	Sep 8, 2015
Priority date	—
Expiry date	Jun 15, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

An in vitro diagnostic method for determining invasive potential of cancer comprising measuring MLK4 gene expression in a cancer cell sample, wherein MLK4 gene overexpression is indicative of an invasive cancer, preferably a colorectal, bladder, breast, gastric, melanoma, lung, ovary or GMB cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.